112 related articles for article (PubMed ID: 707893)
1. Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole.
Levine HB; Cobb JM
Am Rev Respir Dis; 1978 Oct; 118(4):715-21. PubMed ID: 707893
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice.
Levine HB; Ringel SM; Cobb JM
Chest; 1978 Feb; 73(2):202-6. PubMed ID: 620582
[TBL] [Abstract][Full Text] [Related]
3. A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis.
Levine HB
Sabouraudia; 1984; 22(1):37-46. PubMed ID: 6322362
[TBL] [Abstract][Full Text] [Related]
4. Ketoconazole in early and late murine coccidioidomycosis.
Levine HB; Cobb JM
Rev Infect Dis; 1980; 2(4):546-50. PubMed ID: 6255530
[TBL] [Abstract][Full Text] [Related]
5. R34000, a dioxolane imidazole in the therapy for experimental coccidioidomycosis. Comparison with miconazole and econazole.
Levine HB
Chest; 1976 Dec; 70(6):755-9. PubMed ID: 1001052
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic evaluation of ketoconazole in patients with coccidioidomycosis.
Welsh O; González JG; Diaz M; Madero D; González J
Rev Infect Dis; 1980; 2(4):651-5. PubMed ID: 6255546
[TBL] [Abstract][Full Text] [Related]
7. Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis.
Hoeprich PD; Merry JM
Eur J Clin Microbiol; 1985 Aug; 4(4):400-3. PubMed ID: 4043057
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.
Shubitz LF; Galgiani JN; Tian ZQ; Zhong Z; Timmermans P; Katz L
Antimicrob Agents Chemother; 2006 Oct; 50(10):3467-9. PubMed ID: 17005834
[TBL] [Abstract][Full Text] [Related]
9. Therapy of disseminated or pulmonary coccidioidomycosis with ketoconazole.
Brass C; Galgiani JN; Campbell SC; Stevens DA
Rev Infect Dis; 1980; 2(4):656-60. PubMed ID: 6255547
[TBL] [Abstract][Full Text] [Related]
10. Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study.
DeFelice R; Galgiani JN; Campbell SC; Palpant SD; Friedman BA; Dodge RR; Weinberg MG; Lincoln LJ; Tennican PO; Barbee RA
Am J Med; 1982 Apr; 72(4):681-7. PubMed ID: 6280499
[TBL] [Abstract][Full Text] [Related]
11. Miconazole therapy for coccidioidomycosis.
Hoeprich PD; Goldstein E
JAMA; 1974 Nov; 230(8):1153-7. PubMed ID: 4479523
[No Abstract] [Full Text] [Related]
12. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro.
Levine HB; Stevens DA; Cobb JM; Gebhardt AE
J Infect Dis; 1975 Oct; 132(4):407-14. PubMed ID: 1185010
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo.
Kirkland TN; Fierer J
Antimicrob Agents Chemother; 1983 Dec; 24(6):921-4. PubMed ID: 6660859
[TBL] [Abstract][Full Text] [Related]
14. Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis.
Stevens DA; Stiller RL; Williams PL; Sugar AM
Am J Med; 1983 Jan; 74(1B):58-63. PubMed ID: 6295153
[TBL] [Abstract][Full Text] [Related]
15. [Oral ketoconazole therapy of a case of pulmonary histoplasmosis].
Zellweger JP
Schweiz Med Wochenschr; 1981 Feb; 111(6):190-1. PubMed ID: 6261325
[TBL] [Abstract][Full Text] [Related]
16. Ketoconazole for treatment of chronic pulmonary coccidioidomycosis.
Ross JB; Levine B; Catanzaro A; Einstein H; Schillaci R; Friedman PJ
Ann Intern Med; 1982 Apr; 96(4):440-3. PubMed ID: 6279005
[TBL] [Abstract][Full Text] [Related]
17. Disseminated cutaneous coccidioidomycosis masquerading as lupus pernio.
Newlon HR; Lambiase MC
Cutis; 2010 Jul; 86(1):25-8. PubMed ID: 21049763
[TBL] [Abstract][Full Text] [Related]
18. Treatment of murine coccidioidomycosis with polymyxin B.
Collins MS; Pappagianis D
Antimicrob Agents Chemother; 1976 Aug; 10(2):318-21. PubMed ID: 185950
[TBL] [Abstract][Full Text] [Related]
19. Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2004 Jun; 48(6):2140-3. PubMed ID: 15155212
[TBL] [Abstract][Full Text] [Related]
20. The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.
Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Birch M; Law D; Rex JH; Catano G; Patterson TF
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
